COMMUNIQUÉS West-GlobeNewswire

Publication of the annual report and invitation to the annual shareholders' meeting
23/03/2018
Mechelen, Belgium; 23 March 2018, 21.30 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) published its annual report for the financial year 2017. The annual report for the financial year 2017, [...]
DBV Technologies Announces Closing of Global Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
23/03/2018
Montrouge, France, March 23, 2018 DBV Technologies Announces Closing of Global Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares DBV Technologies (the "Company") (Euronext: DBV - ISIN: [...]
DBV Technologies annonce la réalisation de son offre globale et l'exercice de la totalité de l'option de surallocation
23/03/2018
Montrouge, France, 23 Mars 2018, 21h00 CET DBV Technologies annonce la réalisation de son offre globale et l'exercice de la totalité de l'option de surallocation DBV Technologies (la « Société ») (Euronext : DBV - ISIN [...]
IntelGenx to Report Fourth Quarter and Full-Year 2017 Financial Results on March 29, 2018 – Conference Call to Follow
23/03/2018
SAINT LAURENT, Quebec, March 23, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) today announced that it will release its fourth quarter and full year 2017 financial results after [...]
Corizon Health Names New CMO
23/03/2018
BRENTWOOD, Tenn., March 23, 2018 (GLOBE NEWSWIRE) -- James E. “Pete” Powell, MD, MMHC, has been named Chief Medical Officer of Corizon Health. Corizon Chief Executive Officer Steve Rector announced the addition to his [...]
K2M Group Holdings, Inc. to Participate in the 17th Annual Needham Healthcare Conference
23/03/2018
LEESBURG, Va., March 23, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
Heart Institute Inaugurates State-of-The-Art Building Expansion
23/03/2018
OTTAWA, March 23, 2018 (GLOBE NEWSWIRE) -- At an Official Inauguration Ceremony held today at the University of Ottawa Heart Institute, Dr. Thierry Mesana, President and CEO, joined Yasir Naqvi, Ontario’s Attorney [...]
L’Institut de cardiologie inaugure ses nouvelles installations de pointe
23/03/2018
OTTAWA, 23 mars 2018 (GLOBE NEWSWIRE) -- Aujourd’hui, dans le cadre de la cérémonie d’inauguration officielle du nouvel édifice de l’Institut de cardiologie de l’Université d’Ottawa, le Dr Thierry Mesana, président- [...]
eFFECTOR Announces Appointment of John W. Smither to its Board of Directors
23/03/2018
SAN DIEGO, March 23, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced the appointment of John W. [...]
RuddCo Inc. Announces Cannabis Operations Expansion into Jamaica
23/03/2018
MIAMI, March 23, 2018 (GLOBE NEWSWIRE) -- RuddCo Inc., a Florida based company, is announcing an expansion of agricultural operations and the opening of tourist attractions on the island of Jamaica. RuddCo Inc. intends [...]
TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn's disease in Europe
23/03/2018
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION TiGenix and Takeda announce Alofisel ® (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn's disease in Europe First allogeneic stem cell [...]
TiGenix et Takeda annoncent l'autorisation d'Alofisel® (darvadstrocel) pour le traitement des fistules périanales complexes dans la maladie de Crohn en Europe
23/03/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS RÈGLEMENTÉES INFORMATIONS PRIVILÉGIÉES TiGenix et Takeda annoncent l'autorisation d'Alofisel ® (darvadstrocel) pour le traitement des fistules périanales complexes dans la maladie de [...]
Spine Injury Solutions Schedules Fiscal Year 2017 Conference Call for March 29, 2018 at 4:20 p.m. ET
23/03/2018
HOUSTON, March 23, 2018 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN) will hold a conference call on Thursday, March 29 at 4:20 p.m. ET to discuss its financial results for the fourth quarter and fiscal [...]
MJ Biotech Inc. Florida’s MarijuanaDoctor.com Q & A on MoneyTV.NET
23/03/2018
CHEYENNE, Wyo., March 23, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) announced that the awaited Company update will be available at 10AM Eastern time, Monday March 26, [...]
Progressive Care Announces 2017 Annual Report Conference Call and Webcast with Investors on March 27, 2018
23/03/2018
MIAMI, March 23, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced today that it will host its 2017 Annual Report financial results conference call on [...]
CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies
23/03/2018
LOS ANGELES, March 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (“CURE” or the “Company”) (OTC:CURR), an innovative drug delivery and development company, today announced that the Company will participate in an [...]
Alzheimer’s Virtual Reality Sensory Experience Featured at Upcoming ASA Workshop
23/03/2018
SAN FRANCISCO, March 23, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA)—in collaboration with Greener Media —is hosting a workshop titled, "What Would You Do: A Sensory Experience" at this year’s [...]
Portola Pharmaceuticals Receives and Plans to Appeal Negative CHMP Opinion Regarding Marketing Authorization for Betrixaban in the European Union
23/03/2018
SOUTH SAN FRANCISCO, Calif., March 23, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines [...]
CURE Pharmaceutical Announces Closing of $1 Million Bridge Financing and Prepares to Uplist to NASDAQ
23/03/2018
OXNARD, Calif., March 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced that it secured a $1 million bridge financing from accredited [...]

Pages